Cénac A, Develoux M, Lamothe F, Soubiran G, Vetter J M, Trepo C
Bull Soc Pathol Exot Filiales. 1985;78(5 Pt 2):896-902.
From December 1982 to June 1985, 185 patients with signs of chronic liver disease are investigated in National Hospital (Niamey, Republic of Niger). A first group ("Hepatopathy") of 131 patients (75 males, 56 females) is made of 3 chronic liver diseases: 35 chronic hepatitis (CH), 58 hepatic cirrhosis (HC), 38 hepatocellular carcinoma (HCC). A second group ("Controls") of 54 patients (29 males, 25 females) is made of miscellaneous diseases other than CH, HC, HCC. In the first group ("Hepatopathy") serum hepatitis B virus (HBV) surface antigen (HBsAg-radioimmunoassay) is present in 64.9% (85/131). In the second group ("Controls") serum HBsAg is present in 3.7% (2/54) (Chi-2 test P less than 10(-9)). Serum HBsAg prevalence is more than 50% in each group of CH, HC and HCC. A maximum value is observed in males with HCC (75.7%). These results demonstrate the importance of evolutive HBV infection in the course of CH, HC and HCC in the sahelian region.
1982年12月至1985年6月,尼亚美国立医院(尼日尔共和国)对185例有慢性肝病体征的患者进行了调查。第一组(“肝病组”)131例患者(男75例,女56例)由3种慢性肝病组成:35例慢性肝炎(CH)、58例肝硬化(HC)、38例肝细胞癌(HCC)。第二组(“对照组”)54例患者(男29例,女25例)由CH、HC、HCC以外的其他杂病组成。在第一组(“肝病组”)中,血清乙型肝炎病毒(HBV)表面抗原(HBsAg-放射免疫测定)阳性率为64.9%(85/131)。在第二组(“对照组”)中,血清HBsAg阳性率为3.7%(2/54)(卡方检验P<10⁻⁹)。CH、HC和HCC每组的血清HBsAg患病率均超过50%。在男性HCC患者中观察到最高值(75.7%)。这些结果表明,在萨赫勒地区,演变中的HBV感染在CH、HC和HCC病程中具有重要意义。